Vertebral Compression Fracture Devices Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Vertebral Compression Fracture Devices Market size was valued at around USD 1.2 billion in 2023 and is estimated to grow at 7.8% CAGR from 2023 to 2032. Factors such as increasing prevalence of osteoporosis, technological advancements in vertebral compression fracture devices, increasing aging population and growing demand for minimally invasive surgical procedures are expected to propel the market growth.
The growing prevalence of osteoporosis conditions along with surging patient population of spine related disorders has led to an increased adoption of vertebral compression fracture devices. Osteoporosis is more common in older individuals worldwide as the increased susceptibility to bone loss and fracture increases the risk of osteoporosis in older individuals.
For instance, according to data published in an article by Amgen Inc., the number of fractures due to osteoporosis per year in the U.S. is projected to increase by 68% from 1.9 million to 3.2 million between 2018 to 2040. Further, an estimated 10 million individuals in the U.S., over the age of 50, suffers from osteoporosis. An additional 16 million men and little over 43 million women have poor bone mass, which increases their risk of osteoporosis.
Vertebral compression fracture (VCF) devices are medical devices designed to treat fractures in the vertebral column, particularly fractures resulting from conditions such as osteoporosis or trauma. These devices aim to provide stability to the affected vertebrae and alleviate associated symptoms such as pain and deformity and often used for minimally invasive procedures like vertebroplasty or kyphoplasty.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Vertebral Compression Fracture Devices Market size in 2023: | USD 1.2 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2023 - 2032 CAGR: | 7.8 |
2023 Value Projection: | USD 2.3 Billion |
Historical Data for: | 2018 – 2023 |
No of Pages: | 100 |
Tables, Charts & Figures: | 188 |
Segments Covered: | Product type, Surgery, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
The technological advancements in vertebral compression fracture devices including adoption of smart balloon kyphoplasty systems, patient-specific implants, and biocompatible materials among others are proving beneficial for the industry growth.
Based on product type, the market is categorized into balloon kyphoplasty and vertebroplasty. The balloon kyphoplasty segment accounted for majority share and was valued at USD 1,038.4 million revenue in 2023.
Based on surgery, the vertebral compression fracture devices market is segmented into minimally invasive spine surgery and open spine surgery. The minimally invasive spine surgery segment held leading revenue share in 2023 and is anticipated to reach USD 2.1 billion by 2032.
Based on end-user segmentation, the vertebral compression fracture devices market is categorized into hospitals, ambulatory surgical centers, trauma centers, and other end-users. The hospitals segment accounted for majority revenue share and was valued at around USD 632.8 million revenue in 2023.
North America vertebral compression fracture devices market accounted for USD 693.3 million revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
The vertebral compression fracture devices industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency, better pain management and cost-effectiveness is among a key market strategy for VCF device manufacturers. Some of the leading industry players including Becton, Dickinson and Company, Boston Scientific Corporation, Johnson & Johnson (DePuy Synthes), Stryker Corporation, and Medtronic, Plc among others have a substantial presence in the market.
Some of the eminent market participants operating in the vertebral compression fracture devices industry include:
Market, By Product Type
Market, By Surgery
Market, By End-use
The above information is provided for the following regions and countries:
The global vertebral compression fracture devices market was valued at around USD 1.2 billion in 2023 and is expected to reach over USD 2.3 billion by 2032 due to increasing prevalence of osteoporosis and technological advancements in devices.
The balloon kyphoplasty segment accounted for USD 1.03 billion in 2023 and will grow significantly through 2032 as the technique is safer and more effective due to advancements in cement delivery systems, balloon design, and imaging guidance, which increases its demand in patients and healthcare professionals.
North America vertebral compression fracture devices market accounted for USD 693.3 million in 2023 and is predicted to witness substantial growth through 2032 due to the high rate of surgeries in the region.
Becton, Dickinson and Company, Boston Scientific Corporation, IZI Medical Products, Johnson & Johnson (DePuy Synthes), Medtronic Plc, Merit Medical Systems Inc, Spine Wave, Inc, Spirit Spine Holdings Corporation Inc., Stryker Corporation, and Zimmer Biomet Holdings, Inc.